KD Treatment for Super-refractory Status Epilepticus

NCT07496749 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
84
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Xuanwu Hospital, Beijing